FDA Import Refusal 1FX-4495920-2/20002/4 — Intas Pharmaceuticals Limited
The FDA refused shipment 1FX-4495920-2/20002/4 from Intas Pharmaceuticals Limited (India) on May 13, 2026. The refused product falls under Drugs and Biologics — ANTI-CONVULSANT, N.E.C.. Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- May 13, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61MCA99 ANTI-CONVULSANT, N.E.C.
- Charges
- 118,75